Growth Failure

Growth Failure is the indication for 5 drugs in DrugBank. It is covered by 13 curated, structured indications.

Classified under: Musculoskeletal and Connective Tissue Diseases
Nutritional and Metabolic Diseases
Indicated drugs: Lonapegsomatropin
Mecasermin rinfabate
Somapacitan
Somatotropin
Somatrogon

Resolves to

Vocabularies

MedDRA10071095UMLSC0878787

What you can answer from here — as of October 26, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

13Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

7Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Growth Failure share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.